Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases—a multicenter retrospective study

Fig. 3

Typical examples in patients treated with alectinib. A Patient 1 who received first-line alectinib experienced significant alleviation in headache. B Headache and dizziness disappeared in patient 2 who received alectinib after the progression of crizotinib. C Headache and vomiting were largely improved in patient 3 who developed CNS progression following the treatment of ceritinib

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us